Diamyd Medical Ab
Clinical trials sponsored by Diamyd Medical Ab, explained in plain language.
-
New shot aims to save Insulin-Making cells in type 1 diabetes
Disease control OngoingThis study tests a treatment called Diamyd in people aged 12 to 29 who were recently diagnosed with type 1 diabetes and have a specific genetic marker. The goal is to see if it can help preserve the body's ability to produce insulin, which may lead to better blood sugar control. …
Phase: PHASE3 • Sponsor: Diamyd Medical AB • Aim: Disease control
Last updated May 17, 2026 02:39 UTC
-
Could a simple shot stop type 1 diabetes before it starts?
Prevention OngoingThis study tests a treatment called Diamyd® in children aged 8 to 17 who are at high risk for type 1 diabetes. The goal is to see if giving the drug directly into lymph nodes is safe and can delay or prevent the disease from developing. Only 5 children with a specific genetic mar…
Phase: PHASE2 • Sponsor: Diamyd Medical AB • Aim: Prevention
Last updated May 14, 2026 12:04 UTC